Skip to main content
Article thumbnail
Location of Repository

Lineage specific composition of cyclin D–CDK4/CDK6–p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin

By V Bryja, J Pacherník, J Vondráček, K Souček, L Čajánek, V Horvath, Z Holubcová, P Dvořák and A Hampl


Objectives: This article is to study the role of G1/S regulators in differentiation of pluripotent embryonic cells. Materials and methods: We established a P19 embryonal carcinoma cell-based experimental system, which profits from two similar differentiation protocols producing endodermal or neuroectodermal lineages. The levels, mutual interactions, activities, and localization of G1/S regulators were analysed with respect to growth and differentiation parameters of the cells. Results and Conclusions: We demonstrate that proliferation parameters of differentiating cells correlate with the activity and structure of cyclin A/E–CDK2 but not of cyclin D–CDK4/6–p27 complexes. In an exponentially growing P19 cell population, the cyclin D1–CDK4 complex is detected, which is replaced by cyclin D2/3–CDK4/6–p27 complex following density arrest. During endodermal differentiation kinase-inactive cyclin D2/D3–CDK4–p27 complexes are formed. Neural differentiation specifically induces cyclin D1 at the expense of cyclin D3 and results in predominant formation of cyclin D1/D2–CDK4–p27 complexes. Differentiation is accompanied by cytoplasmic accumulation of cyclin Ds and CDK4/6, which in neural cells are associated with neural outgrowths. Most phenomena found here can be reproduced in mouse embryonic stem cells. In summary, our data demonstrate (i) that individual cyclin D isoforms are utilized in cells lineage specifically, (ii) that fundamental difference in the function of CDK4 and CDK6 exists, and (iii) that cyclin D–CDK4/6 complexes function in the cytoplasm of differentiated cells. Our study unravels another level of complexity in G1/S transition-regulating machinery in early embryonic cells

Topics: Original Articles
Publisher: Blackwell Publishing Ltd
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1995). Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
  2. (1996). Abundance and subcellular localisation of cyclin D3 in human tumours.
  3. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
  4. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression.
  5. (2004). Cdk6-cyclin D3 activity in murine ES cells is resistant to inhibition by p16INK4a.
  6. (2001). Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell’s proliferation competence.
  7. (1999). Cerebellar histogenesis is disturbed in mice lacking cyclin D2.
  8. (1998). Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development.
  9. (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast.
  10. (1997). Cyclins, cyclin-dependent kinases and differentiation.
  11. (1995). D-type cyclins.
  12. (2002). Development of mice expressing a single D-type cyclin.
  13. (2006). Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells.
  14. (2001). Embryonal carcinoma cells as embryonic stem cells. In:
  15. (2001). Embryonic stem cells. In:
  16. (2001). Executioner caspase-3-6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis.
  17. (2004). FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells.
  18. (2005). Fornace AJ Jr
  19. (2005). Hampl A
  20. Hampl A (2002) Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.
  21. Hampl A (2004a) The role of p27(Kip1) in maintaining the levels of D-type cyclins in vivo.
  22. Hampl A (2004b) Increased apoptosis in differentiating p27-deficient mouse embryonic stem cells. Cell Mol. Life Sci.
  23. (2008). Histone H2AX-dependent GABAA receptor regulation of stem cell proliferation.
  24. (1999). Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.
  25. (1995). Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
  26. (2003). Microarray analysis of knockout mice identifies cyclin D2 as a possible mediator for the action of thyroid hormone during the postnatal development of the cerebellum.
  27. (1994). MN20, a D2 cyclin found in brain, is implicated in neural differentiation.
  28. (1996). MN20, a D2 cyclin, is transiently expressed in selected neural populations during embryogenesis.
  29. (2004). Mouse development and cell proliferation in the absence of D-cyclins.
  30. (1999). pRb phosphorylation is regulated differentially by cyclin-dependent kinase (Cdk) 2 and Cdk4 in retinoic acid-induced neuronal differentiation of P19 cells.
  31. (2005). Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
  32. (1998). Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
  33. (2000). Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle.
  34. (2000). Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasomedependent proteolysis of the cyclin-dependent inhibitor p27.
  35. (2001). Retinoic acid- and bone morphogenetic protein 4-induced apoptosis in P19 embryonal carcinoma cells requires p27. Exp. Cell Res.
  36. (2003). Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons.
  37. (1998). Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
  38. (2008). The Authors Journal compilation ©
  39. (1999). The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
  40. (1995). Withdrawal of differentiation inhibitory activity/ leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.